A British pharmaceutical watchdog said on Friday that it is reviewing its consultation process after coming under attack for recommending that a multiple sclerosis drug should not be given free to sufferers. As NICE disclosed in its review, the MS Society of Great Britain and Northern Ireland, a charity, said that the Institute had refused to meet with sufferers face to face. MS is incurable and causes the body's immune system to destroy a sheath protecting nerve cells in the brain and spinal cord, causing paralysis, pain and tremors.
Users say that beta interferon reduces the frequency and severity of painful bouts.